Demographic and baseline characteristics of subjects
| . | Placebo . | ACE910 (mg/kg) . | ||||
|---|---|---|---|---|---|---|
| 0.001 . | 0.01 . | 0.1 . | 0.3 . | 1 . | ||
| Japanese | ||||||
| N | 10 | 6 | 6 | 6 | 6 | 6 |
| Age (y) | 28.1 ± 7.45 | 33.0 ± 7.56 | 33.0 ± 7.97 | 29.7 ± 7.66 | 34.2 ± 4.36 | 29.8 ± 7.78 |
| Body weight (kg) | 60.2 ± 5.47 | 62.9 ± 4.21 | 62.9 ± 4.24 | 61.3 ± 6.04 | 59.0 ± 3.28 | 61.2 ± 5.04 |
| BMI (kg/m2) | 20.9 ± 1.77 | 21.6 ± 1.68 | 21.3 ± 1.55 | 21.6 ± 1.24 | 20.7 ± 0.77 | 21.1 ± 1.48 |
| White | ||||||
| N | 6 | NA | NA | 6 | 6 | 6 |
| Age (y) | 30.5 ± 3.27 | NA | NA | 30.3 ± 6.06 | 29.7 ± 5.65 | 32.2 ± 9.47 |
| Body weight (kg) | 72.1 ± 8.93 | NA | NA | 69.4 ± 6.65 | 69.9 ± 7.06 | 74.8 ± 9.21 |
| BMI (kg/m2) | 22.7 ± 2.55 | NA | NA | 22.3 ± 2.39 | 21.4 ± 1.34 | 22.3 ± 1.79 |
| . | Placebo . | ACE910 (mg/kg) . | ||||
|---|---|---|---|---|---|---|
| 0.001 . | 0.01 . | 0.1 . | 0.3 . | 1 . | ||
| Japanese | ||||||
| N | 10 | 6 | 6 | 6 | 6 | 6 |
| Age (y) | 28.1 ± 7.45 | 33.0 ± 7.56 | 33.0 ± 7.97 | 29.7 ± 7.66 | 34.2 ± 4.36 | 29.8 ± 7.78 |
| Body weight (kg) | 60.2 ± 5.47 | 62.9 ± 4.21 | 62.9 ± 4.24 | 61.3 ± 6.04 | 59.0 ± 3.28 | 61.2 ± 5.04 |
| BMI (kg/m2) | 20.9 ± 1.77 | 21.6 ± 1.68 | 21.3 ± 1.55 | 21.6 ± 1.24 | 20.7 ± 0.77 | 21.1 ± 1.48 |
| White | ||||||
| N | 6 | NA | NA | 6 | 6 | 6 |
| Age (y) | 30.5 ± 3.27 | NA | NA | 30.3 ± 6.06 | 29.7 ± 5.65 | 32.2 ± 9.47 |
| Body weight (kg) | 72.1 ± 8.93 | NA | NA | 69.4 ± 6.65 | 69.9 ± 7.06 | 74.8 ± 9.21 |
| BMI (kg/m2) | 22.7 ± 2.55 | NA | NA | 22.3 ± 2.39 | 21.4 ± 1.34 | 22.3 ± 1.79 |
Data are presented as mean ± standard deviation.
NA, not applicable.